Here are the 424B prospectus supplements from Inventiva SA ACT Porteur (IVEVF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IVEVF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVEVF filings page.
We are offering 27,272,727 ADSs, each representing one ordinary share. The offering price is $4.40 per ADS for gross proceeds of $119,999,999 and estimated net proceeds of approximately $110.8M (€95.2M). We currently intend to use the net proceeds to repay in full our EIB loans and, together with proceeds from a new debt financing, to fund the repurchase of a portion of the EIB warrants; remaining funds under that debt commitment would fund continued development and potential commercialization of lanifibranor and general corporate purposes. The offering and related financings are interlinked: the Subscription Agreement with BlackRock and Claret and the EIB Master Agreement are conditioned on this equity financing and certain other conditions, and Tranche A/B initial debt closings are expected in mid-June 2026, subject to those conditions.